DekaBank Deutsche Girozentrale’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$146M Hold
748,680
0.25% 94
2026
Q1
$149M Hold
748,680
0.25% 94
2025
Q4
$114M Hold
748,680
0.2% 118
2025
Q3
$141M Hold
748,680
0.24% 98
2025
Q2
$133M Sell
748,680
-17,258
-2% -$3M 0.24% 102
2025
Q1
$127M Buy
765,938
+17,258
+2% +$2.84M 0.25% 102
2024
Q4
$113M Hold
748,680
0.21% 109
2024
Q3
$116M Buy
748,680
+15,047
+2% +$2.25M 0.21% 115
2024
Q2
$101M Sell
733,633
-32,305
-4% -$4.42M 0.18% 125
2024
Q1
$100M Sell
765,938
-12,808
-2% -$1.66M 0.19% 129
2023
Q4
$107M Sell
778,746
-16,891
-2% -$2.22M 0.22% 111
2023
Q3
$98M Buy
795,637
+51,786
+7% +$6.9M 0.23% 104
2023
Q2
$105M Buy
743,851
+24,493
+3% +$3.38M 0.24% 105
2023
Q1
$99.8M Buy
719,358
+63,177
+10% +$9.04M 0.25% 105
2022
Q4
$103M Buy
656,181
+28,739
+5% +$4.13M 0.27% 90
2022
Q3
$77.8M Buy
627,442
+143,941
+30% +$19M 0.23% 113
2022
Q2
$66.2M Buy
483,501
+40,369
+9% +$5.5M 0.19% 129
2022
Q1
$61.6M Sell
443,132
-96,937
-18% -$13.5M 0.15% 154
2021
Q4
$92M Sell
540,069
-9,650
-2% -$1.47M 0.22% 112
2021
Q3
$81.5M Buy
549,719
+11,984
+2% +$1.75M 0.23% 115
2021
Q2
$71.2M Buy
537,735
+103,828
+24% +$13.6M 0.21% 127
2021
Q1
$55.6M Buy
433,907
+156,753
+57% +$19.3M 0.18% 138
2020
Q4
$32.9M Buy
277,154
+16,388
+6% +$2M 0.12% 173
2020
Q3
$29.4M Buy
260,766
+186,351
+250% +$22M 0.13% 153
2020
Q2
$8.19M Buy
74,415
+5,529
+8% +$586K 0.05% 235
2020
Q1
$5.63M Buy
68,886
+54,961
+395% +$5.69M 0.04% 260
2019
Q4
$1.48M Sell
13,925
-23,852
-63% -$2.49M 0.01% 598
2019
Q3
$4.03M Sell
37,777
-19,973
-35% -$2.05M 0.03% 390
2019
Q2
$5.86M Sell
57,750
-117,378
-67% -$11.3M 0.03% 395
2019
Q1
$19.4M Buy
175,128
+46,385
+36% +$4.02M 0.12% 197
2018
Q4
$10.7M Sell
128,743
-46,385
-26% -$4.35M 0.07% 250
2018
Q3
$19.4M Sell
175,128
-21,592
-11% -$2.37M 0.11% 199
2018
Q2
$21.7M Buy
196,720
+659
+0.3% +$68.7K 0.14% 175
2018
Q1
$19.6M Buy
196,061
+31,204
+19% +$3.2M 0.13% 179
2017
Q4
$17.7M Hold
164,857
0.14% 169
2017
Q3
$17.7M Sell
164,857
-133
-0.1% -$14.1K 0.14% 169
2017
Q2
$18.3M Buy
164,990
+33,091
+25% +$3.5M 0.15% 155
2017
Q1
$13M Buy
131,899
+50,265
+62% +$4.79M 0.12% 190
2016
Q4
$7.49M Sell
81,634
-456
-0.6% -$39.3K 0.08% 239
2016
Q3
$6.86M Buy
82,090
+14,538
+22% +$1.22M 0.08% 259
2016
Q2
$5.42M Buy
67,552
+46,800
+226% +$3.56M 0.06% 288
2016
Q1
$1.5M Sell
20,752
-5,300
-20% -$355K 0.02% 492
2015
Q4
$1.88M Sell
26,052
-1,828
-7% -$123K 0.02% 469
2015
Q3
$1.71M Buy
27,880
+62
+0.2% +$4.33K 0.02% 473
2015
Q2
$2M Buy
27,818
+5,470
+24% +$404K 0.02% 446
2015
Q1
$1.73M Sell
22,348
-685
-3% -$49.1K 0.02% 472
2014
Q4
$1.56M Buy
23,033
+1,707
+8% +$108K 0.02% 501
2014
Q3
$1.31M Sell
21,326
-1,546
-7% -$95.3K 0.02% 483
2014
Q2
$1.34M Buy
22,872
+1,202
+6% +$70.4K 0.02% 461
2014
Q1
$1.25M Sell
21,670
-19,776
-48% -$1.06M 0.02% 441
2013
Q4
$2.23M Buy
41,446
+8,754
+27% +$519K 0.04% 308
2013
Q3
$2.01M Buy
32,692
+8,217
+34% +$492K 0.04% 317
2013
Q2
$1.49M Buy
+24,475
New +$1.46M 0.03% 311

Other funds holding DGX

DekaBank Deutsche Girozentrale's DGX Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Quest Diagnostics (DGX) position steady in Q2 2026 at 748,680 shares worth $146M. The position accounts for 0.25% of the portfolio, ranked #94.

DekaBank Deutsche Girozentrale first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $149M in Q1 2026. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • DekaBank Deutsche Girozentrale held 748,680 shares of Quest Diagnostics worth $146M as of Q2 2026.
  • DekaBank Deutsche Girozentrale left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.25% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #94 holding.
  • DekaBank Deutsche Girozentrale first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • DekaBank Deutsche Girozentrale's Quest Diagnostics position peaked at $149M in Q1 2026.
  • 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.